Consistent with this hypothesis are the observations that microangiopathy in the lung is highly prevalent among COVID-19 patients with CAC [125,141,142,143], and that age-associated increase, specifically in cellular expression of VWF, is observed in lung microvasculature [82]. The gene discussed is VWF; the disease is COVID-19.